NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,697 Cr | ₹1,212 Cr | ₹849 Cr | ₹47 Cr | ₹299 Cr |
What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1,697 Cr |
| Mar2024 | ₹1,212 Cr |
| Mar2023 | ₹849 Cr |
| Mar2022 | ₹47 Cr |
| Mar2021 | ₹299 Cr |
How is Cash Flow from Operating Activities of NATCO PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,697 Cr | 40.05 | |
| Mar2024 | ₹1,212 Cr | 42.69 | |
| Mar2023 | ₹849 Cr | 1,726.02 | |
| Mar2022 | ₹47 Cr | -84.44 | |
| Mar2021 | ₹299 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,838.7 Cr | 3.9% | -24.6% | -1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,104.0 Cr | 3.5% | -1.5% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,119.0 Cr | 1.1% | -1.1% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,871.0 Cr | -0.2% | -0.3% | 35% | Stock Analytics | |
| CIPLA | ₹114,334.0 Cr | 3.1% | 1% | -11.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,761.0 Cr | 1.1% | -2.1% | -5.6% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 3.9% |
-24.6% |
-1.6% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses